Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.531
+0.001 (0.04%)
Mar 9, 2026, 1:40 PM EDT - Market open
Serina Therapeutics Revenue
Serina Therapeutics had revenue of $116.00K in the twelve months ending September 30, 2025, down -96.33% year-over-year. In the year 2024, Serina Therapeutics had annual revenue of $56.00K, down -98.22%.
Revenue (ttm)
$116.00K
Revenue Growth
-96.33%
P/S Ratio
142.26
Revenue / Employee
$8,923
Employees
13
Market Cap
16.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
| Dec 31, 2023 | 3.15M | 2.56M | 433.05% |
| Dec 31, 2022 | 591.50K | -2.87M | -82.93% |
| Dec 31, 2021 | 3.46M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSER News
- 12 days ago - Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease - GlobeNewsWire
- 18 days ago - Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease - GlobeNewsWire
- 4 weeks ago - Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson's disease - GlobeNewsWire
- 7 weeks ago - Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity - GlobeNewsWire
- 3 months ago - Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry - GlobeNewsWire
- 3 months ago - Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program - GlobeNewsWire
- 4 months ago - Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire